Inventor · disambiguated record
Hans Roland Lonn
Also filed as: LOENN HANS · LOENN HANS ROLAND · LONN HANS · LONN HANS ROLAND
24 granted patents·14 pending applications·171 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
38 records- 0198US12054465B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Granted Aug 6, 2024·3 cites·21 claims
- 0298US11814359B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Nov 14, 2023·4 cites·21 claims
- 0398US11773069B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Oct 3, 2023·6 cites·23 claims
- 0498US11680049B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 20, 2023·5 cites·14 claims
- 0598US11117874B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2020·Granted Sep 14, 2021·15 cites·60 claims
- 0698US10669245B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2019·Granted Jun 2, 2020·16 cites·16 claims
- 0798US9815805B2Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2016·Granted Nov 14, 2017·22 cites·14 claims
- 0897US11673871B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·20 claims
- 0997US11673872B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·14 claims
- 1097US11667615B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·5 cites·15 claims
- 1197US11655222B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1297US11655221B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·22 claims
- 1397US11655223B2Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·21 claims
- 1497US11655224B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1597US10287258B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2017·Granted May 14, 2019·18 cites·6 claims
- 1697US9522894B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2015·Granted Dec 20, 2016·25 cites·8 claims
- 1791US2024336582A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1887US2023250071A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1983US2024041896A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2077US2022133737A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 2176US8232296B2Salt 628BRIGGNER LARS-ERIK·Filed 2010·Granted Jul 31, 2012·11 cites·3 claims
- 2274US2025228870A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 2370US7388020B2Benzimidazol derivatives modulate chemokine receptorsASTRAZENECA AB·Filed 2002·Granted Jun 17, 2008·6 cites·25 claims
- 2469US7998984B22-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficialASTRAZENECA AB·Filed 2007·Granted Aug 16, 2011·1 cites·13 claims
- 2568US2018028541A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors for treating bronchiectasisASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 2667US8466284B2Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastaseCHAPMAN DAVID·Filed 2008·Granted Jun 18, 2013·1 cites·19 claims
- 2767US8063073B22-pyridone derivatives as neutrophil elastase inhibitors and their useHANSEN PETER·Filed 2004·Granted Nov 22, 2011·3 cites·4 claims
- 2866US2020179398A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 2965US2019091236A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 3054US8114881B22-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficialHANSEN PETER·Filed 2007·Granted Feb 14, 2012·0 cites·6 claims
- 3149US2009131483A12-pyridine derivatives as inhibitors of neutrophile elastaseHANSEN PETER·Filed 2006·Application pending·0 cites
- 3245US2007043036A12-Pyridone derivatives as neutrophil elastase inhibitors and their useHANSEN PETER·Filed 2004·Application pending·0 cites
- 3344US8410114B22-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficialHANSEN PETER·Filed 2012·Granted Apr 2, 2013·0 cites·9 claims
- 3444US2009105239A12-pyridine derivatives as inhibitors of neutrophile elastaseBRIMERT THOMAS·Filed 2006·Application pending·0 cites
- 3542US2011003858A1Multimeric heterocyclic compounds useful as neutrophil elastase inhibitorsBERGSTROEM LENA·Filed 2007·Application pending·0 cites
- 3641US2006035938A12-Pyridone derivatives as inhibitors of neutrophile elastaseBLADH HAKAN·Filed 2003·Application pending·0 cites
- 3735US2012269872A1Novel salt 628BRIGGNER LARS-ERIK·Filed 2012·Application pending·0 cites
- 3833US8501784B22-pyridone derivatives as neutrophil elastase inhibitors and their useANDERSSON MARJANA·Filed 2011·Granted Aug 6, 2013·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Hans Roland Lonn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →